Evidence map›Paper›PMID 22242625›Full record

ArticleBiochemistry2012

Solution NMR of a 463-residue phosphohexomutase: domain 4 mobility, substates, and phosphoryl transfer defect.

Akella V S Sarma, Asokan Anbanandam, Allek Kelm, Ritcha Mehra-Chaudhary, Yirui Wei, Peiwu Qin, Yingying Lee, Mark V Berjanskii, Jacob A Mick, Lesa J Beamer and 1 more

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biology, Mechanism, and Structure of Enzymes in the α-d-Phosphohexomutase Superfamily.Advances in protein chemistry and structural biology · 2017
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akella V S SarmaBiochemistry Department, University of Missouri, Columbia, Missouri 65211, United States.
Asokan Anbanandam
Allek Kelm
Ritcha Mehra-Chaudhary
Yirui Wei
Peiwu Qin
Yingying Lee
Mark V Berjanskii
Jacob A Mick
Lesa J Beamer
Steven R Van Doren

Funding

800 MHZ SPECTROMETER FOR BIOMOLECULAR NMR: STRUCTURAL BIOLOGYS10RR022341 · NCRR · UNIVERSITY OF MISSOURI-COLUMBIA · PI VAN DOREN, STEVEN R · 2006 to 2006
$500k
NMR studies of the enzyme PMM/PGM from P. aeruginosaR03AI074779 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI BEAMER, LESA J · 2007 to 2009
$167k
NCRR NIH HHS RR022341NCRR NIH HHS S10 RR022341NIAID NIH HHS R03 AI074779NIAID NIH HHS R03AI074779
6 · The paper itself

Abstract

Phosphomannomutase/phosphoglucomutase contributes to the infectivity of Pseudomonas aeruginosa, retains and reorients its intermediate by 180°, and rotates domain 4 to close the deep catalytic cleft. Nuclear magnetic resonance (NMR) spectra of the backbone of wild-type and S108C-inactivated enzymes were assigned to at least 90%. (13)C secondary chemical shifts report excellent agreement of solution and crystallographic structure over the 14 α-helices, C-capping motifs, and 20 of the 22 β-strands. Major and minor NMR peaks implicate substates affecting 28% of assigned residues. These can be attributed to the phosphorylation state and possibly to conformational interconversions. The S108C substitution of the phosphoryl donor and acceptor slowed transformation of the glucose 1-phosphate substrate by impairing k(cat). Addition of the glucose 1,6-bisphosphate intermediate accelerated this reaction by 2-3 orders of magnitude, somewhat bypassing the defect and apparently relieving substrate inhibition. The S108C mutation perturbs the NMR spectra and electron density map around the catalytic cleft while preserving the secondary structure in solution. Diminished peak heights and faster (15)N relaxation suggest line broadening and millisecond fluctuations within four loops that can contact phosphosugars. (15)N NMR relaxation and peak heights suggest that domain 4 reorients slightly faster in solution than domains 1-3, and with a different principal axis of diffusion. This adds to the crystallographic evidence of domain 4 rotations in the enzyme, which were previously suggested to couple to reorientation of the intermediate, substrate binding, and product release.

Indexed as

Catalytic DomainCrystallography, X-RayNuclear Magnetic Resonance, BiomolecularPhosphoglucomutasePhosphorylationPhosphotransferases (Phosphomutases)Protein BindingProtein TransportPseudomonas aeruginosaSubstrate SpecificityPhosphoglucomutasephosphomannomutasePhosphotransferases (Phosphomutases)

Identifiers

PMID22242625
PMCPMC3448444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.